Eli Lilly's CEO said supply of Zepbound, the drugmaker's new weight loss drug, might not meet 2024 demand. 

Ozempic and other glucagon-like peptide-1 receptor agonists are not linked to a higher risk of pancreatic cancer compared to insulin, according to a recent study. 

Vertex Pharmaceuticals paused a Type 1 diabetes drug trial after two patients died. The drugmaker said the deaths are unrelated to the therapy and that it is waiting on independent review before restarting the study. 

New research points to a challenge patients may face once they stop taking a GLP-1 medication: The number of calories they consume may rise. 

The FDA is looking into 22 reports of patients contracting blood cancer after receiving CAR-T therapy treatment. The move comes after the agency reported initial investigation efforts into cases in November. 

Leiters Health has recalled 33 lots of IV bags filled with vancomycin, phenylephrine and fentanyl because the solutions might contain double the amount labeled. 

Merck is acquiring South San Francisco-based Harpoon Therapeutics, an oncology drugmaker, for approximately $680 million.

Lindsey Amerine, PharmD, was named chief pharmacy officer of Cleveland Clinic, effective Feb. 26. 

Johnson & Johnson plans to acquire Ambrx, a clinical-stage biotechnology company developing cancer treatments, for $1.9 billion. 

Eli Lilly's recent launch of a direct-to-consumer prescription drug website isn't expected to overthrow the pharmaceutical supply chain, but competitors are likely to take inspiration, CNBC reported Jan. 5. 

Sen. Bernie Sanders, I-Vt., and three other legislators on the Health, Education, Labor and Pensions Committee launched an investigation into inhalers, calling the prices "outrageous."

Hospital pharmacies are criticizing Florida's plan to import drugs from Canada, arguing the idea undermines the pharmacist-patient relationship and fails to be a "real solution."

Hospital pharmacy leaders should be vigilant about eradicating the syringe drawback method —  and taking pictures during sterile compounding isn't enough, according to Rita Jew, PharmD, president of the Institute for Safe Medication Practices. 

Ozempic is facing increased competition from compounded versions and rival drugmakers, while potential side effects, including suicidal thoughts and hair loss, have spurred investigations into it and similar drugs.

Stephen Hoang, MD, is the medication safety officer and a pediatric anesthesiologist at Children's Health System of Texas in Dallas. He recently connected with Becker's to share his team's biggest priority for 2024 and proudest accomplishment of 2023.

Contrary to some anecdotal reports, a new study has found semaglutide — the active ingredient in blockbuster weight loss drugs Ozempic and Wegovy — is not linked to increased risks of suicidal thoughts.

Florida has become the first state authorized by the FDA to import prescription drugs from Canada after the agency issued an approval of the Sunshine State's drug importation program Jan. 5.

 Eli Lilly has launched a new website for customers with migraines, obesity and diabetes to order prescription drugs directly from the manufacturer, including weight loss medications such as Zepbound.

Walgreens' new CEO Tim Wentworth says the pressure is on to develop new drug pricing models following a recent shift in the retail pharmacy market "to give patients the Cost Plus experience."

The FDA is looking into whether hair loss, aspiration and suicidal thoughts may be side effects of GLP-1 receptor agonists, a popular class of weight-loss drugs.